Literature DB >> 3422576

The action of the prostaglandins on isolated human ureteric smooth muscle.

R S Cole1, C H Fry, K E Shuttleworth.   

Abstract

A study has been carried out on the actions of the prostaglandins E2 and F2 alpha and their synthesis inhibitors, indomethacin and diclofenac sodium, upon isolated human ureteric smooth muscle, using the technique of microsuperfusion designed to ensure good tissue viability. Indomethacin and diclofenac sodium were shown to abolish almost completely the contractile response of ureteric muscle to electrical field stimulation. Contractile activity, in the presence of the inhibitors, could be restored by prostaglandin E2 or F2 alpha or by increasing the external potassium concentration, [K+]O, of the superfusate. Prostaglandin E2 or F2 alpha alone were shown to increase dramatically both the phasic and tonic component of the electrically stimulated contractions, on occasions inducing spontaneous activity. A possible mechanism of action was elucidated with an electrophysiological technique using intracellular microelectrodes. The mean membrane potential recorded was 54.7 mV (SD +/- 10 mV, n = 15). The depolarising action of raising [K+]O was demonstrated and prostaglandin F2 alpha (3 x 10(-6) M) was shown to produce a small depolarisation of the ureteric muscle cell membrane.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422576     DOI: 10.1111/j.1464-410x.1988.tb09155.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  13 in total

1.  Adjunctive therapy to promote stone passage.

Authors:  Geoffrey R Nuss; Judson D Rackley; Dean G Assimos
Journal:  Rev Urol       Date:  2005

Review 2.  Medical expulsive therapy for distal ureteral stones.

Authors:  Vassilios Tzortzis; Charalampos Mamoulakis; Jorge Rioja; Stavros Gravas; Martin C Michel; Jean J M C H de la Rosette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics.

Authors:  Isao Wanajo; Yoshitaka Tomiyama; Mariko Tadachi; Mamoru Kobayashi; Yoshinobu Yamazaki; Masami Kojima; Nobuo Shibata
Journal:  Urol Res       Date:  2005-08-25

4.  Effects of prostaglandin synthetase inhibitors on the upper urinary tract. Experimental studies on isolated preparations and urodynamic measurements in men.

Authors:  U E Zwergel; T B Zwergel; D A Neisius; M Ziegler
Journal:  Urol Res       Date:  1990

5.  Transgenic overexpression of p23 induces spontaneous hydronephrosis in mice.

Authors:  Jaehoon Lee; Hye Jin Kim; Jung Ah Moon; Young Hoon Sung; In-Jeoung Baek; Jae-il Roh; Na Young Ha; Seung-Yeon Kim; Young Yil Bahk; Jong Eun Lee; Tae Hyun Yoo; Han-Woong Lee
Journal:  Int J Exp Pathol       Date:  2011-02-16       Impact factor: 1.925

6.  The effect of diclofenac sodium and papaverine on isolated human ureteric smooth muscle.

Authors:  Abdullah Sivrikaya; Omer Fatih Celik; Nursel Sivrikaya; Guner Kemal Ozgur
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

7.  Effects of a non-selective COX inhibitor and selective COX-2 inhibitors on contractility of human and porcine ureters in vitro and in vivo.

Authors:  V Chaignat; H Danuser; M H Stoffel; S Z'brun; U E Studer; M Mevissen
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

8.  Effects of intrinsic prostaglandins on the spontaneous contractile and electrical activity of the proximal renal pelvis of the guinea-pig.

Authors:  Y Zhang; R J Lang
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Modulation by stereoselective inhibition of cyclo-oxygenase of electromechanical coupling in the guinea-pig isolated renal pelvis.

Authors:  P Santicioli; G Carganico; S Meini; S Giuliani; A Giachetti; C A Maggi
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study.

Authors:  Kim Davenport; Anthony G Timoney; Francis X Keeley
Journal:  Urol Res       Date:  2007-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.